Logos Global Management LP Astria Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q1 2024
A detailed history of Logos Global Management LP transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,000,000 shares of ATXS stock, worth $9.1 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 544,960
83.5%
Holding current value
$9.1 Million
Previous $4.19 Million
236.2%
% of portfolio
1.31%
Previous 0.45%
Shares
4 transactions
Others Institutions Holding ATXS
# of Institutions
122Shares Held
48.8MCall Options Held
3.59MPut Options Held
483K-
Perceptive Advisors LLC New York, NY6.49MShares$59 Million1.91% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.28MShares$48 Million7.82% of portfolio
-
Vr Adviser, LLC New York, NY3.61MShares$32.8 Million4.36% of portfolio
-
Black Rock Inc. New York, NY3.59MShares$32.6 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$32.3 Million7.97% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $138M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...